Concepedia

Dhania Novitasari

DN

Statistics

Publications

8

Citations

122

H-Index

8

Active since

2020

Affiliations

Universitas Gadjah Mada(Current)

Nara Institute of Science and Technology

Institute of Macromolecular Chemistry

Osaka Prefecture University

Dhania Novitasari is an author at Universitas Gadjah Mada specializing in oncology, anticancer activity, and medicine.

Publications per year

2020–2023

8

Publications

8

CCA-1.1, a Novel Curcumin Analog, Exerts Cytotoxic anti- Migratory Activity toward TNBC and HER2-Enriched Breast Cancer Cells

Dhania Novitasari, Riris Istighfari Jenie, Rohmad Yudi Utomo et al. · Asian Pacific Journal of Cancer Prevention · 2021 · 20 citations · Full text

Medicine, Oncology, Pharmacology +13

Curcumin-like structure (CCA-1.1) induces permanent mitotic arrest (Senescence) on Triple-negative breast cancer (TNBC) cells, 4T1

Dhania Novitasari, Riris Istighfari Jenie, Febri Wulandari et al. · Research Journal of Pharmacy and Technology · 2021 · 20 citations

Medicine, Oncology, Pharmacology +14

Preparation and Cytotoxic Evaluation of PGV-1 Derivative, CCA-1.1, as a New Curcumin Analog with Improved-Physicochemical and Pharmacological Properties

Rohmad Yudi Utomo, Febri Wulandari, Dhania Novitasari et al. · Advanced Pharmaceutical Bulletin · 2021 · 19 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

New curcumin analog, CCA-1.1, synergistically improves the antiproliferative effect of doxorubicin against T47D breast cancer cells

Febri Wulandari, Muthi Ikawati, Dhania Novitasari et al. · INDONESIAN JOURNAL OF PHARMACY · 2020 · 15 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Synthesis of new boron containing compound (CCB-2) based on curcumin structure and its cytotoxic effect against cancer cells

Edy Meiyanto, Ratna Asmah Susidarti, Riris Istighfari Jenie et al. · Journal of Applied Pharmaceutical Science · 2020 · 15 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +7

1–5 of 8